Navigation Links
Sub-Sahara Africa: Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs
Date:2/20/2017

CAPE TOWN, South Africa, Feb. 20, 2017 /PRNewswire/ -- There has been a paradigm shift in the burden of illness and non-communicable diseases (NCDs) across sub-Saharan Africa, which in turn is driving the demand for chronic prescription drugs. The growing incidence of more Western lifestyle diseases such as cardiovascular disease (CVD), cancer, diabetes and respiratory disease, in addition to infectious and parasitic illness, will present the pharmaceutical industry in Africa with a business opportunity of $40.8 billion in 2019.

"An increase in health spending will encourage local manufacture of drugs," said Transformational Health Research Analyst Saravanan Thangaraj. "We expect this increase in local formulation and filling to be protected by regulatory and tariff barriers, so international players will be looking for local contract manufacturers and other strategic partnerships."

African Pharmaceuticals Market, Forecast to 2020, part of Frost & Sullivan's Life Sciences Growth Partnership Service program, provides valuable insights for Big Pharma and generic manufacturers looking to set up manufacturing units in Africa; as well as over-the-counter (OTC) and chronic disease therapeutics manufacturers; large, local enterprises in Kenya and Nigeria; and Tier 1 distributors. In addition to a brief competitive overview, the research details the pricing and regulatory environment, revenues and growth forecasts, as well as market dynamics—particularly challenges, drivers and restraints. Therapeutic areas covered include haematology, oncology, men's health, central nervous system (CNS), women's health, diabetes, cardiovascular, dermatologicals, gastrointestinals, cough and colds, nutritionals, analgesics and anti-infectives.

Click here for complimentary access to more information on this analysis and to register for a Growth Strategy Dialogue, a free interactive briefing with Frost & Sullivan's thought leaders.

Heavy dependence on price, coupled with complexities associated with public sector tendering, make it difficult for multinationals to compete in this space. The private market, on the other hand, faces challenges with regards to fragmented payer channels between donors, private insurance payers and employers, even as high out-of-pocket expenses restrict patient access to medicines.

Nonetheless, several trends are encouraging investment:
The regulatory environment for manufacturing in East Africa is improving rapidly with increasing regional harmonisation
Pharmaceutical spending in Africa was noted to be growing by 10.6 percent
Out-of-pocket spend on healthcare is increasing
The share of OTC drugs is high, indicative of a culture of self-medication in Nigeria and Kenya
Contribution of NCDs to the healthcare burden in Africa will rise by 21 percent through 2030

"Addressing loopholes in the supply chain and distribution channels is crucial for foreign companies to ensure product availability and prevent circulation of counterfeit drugs," added Thangaraj. "Investing in technical training of distributors and pharmacists, and product-specific initiatives like barcodes and holograms to track counterfeits, can also help minimize drug trafficking and enhance the brand's image."

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion

African Pharmaceuticals Market, Forecast to 2020
MC24-52

Contact:
Samantha James
Corporate Communications – Africa
P: +27 21 680 3574
F: +27 21 680 3296
E: samantha.james@frost.com

http://ww2.frost.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sub-sahara-africa-increase-in-western-lifestyles-leads-to-dire-need-for-chronic-prescription-drugs-300409967.html


'/>"/>
SOURCE Frost & Sullivan
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Malaria No More Honors Aleres Contributions to Diagnosing and Eliminating Malaria in sub-Saharan Africa
2. Frost & Sullivan Applauds MEDITECH as Provider of Best-in-class Healthcare Informatics Products in Sub-Saharan Africa
3. Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa
4. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
5. U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015
6. Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
7. New Treatment for Stroke Set to Increase Chances of Recovery
8. Hill-Rom Increases Third Quarter 2013 Dividend
9. For Multiple Sclerosis Treatment, Prescriber Base for Genzymes Aubagio Among U.S. Neurologists Has Increased Significantly at Six Months Post-launch, Compared to One and Three Months Post-launch
10. ResMed Launches SleepSeeker Online Tool to Increase Patient Engagement in Therapy for Sleep-Disordered Breathing
11. DebMed to Display Clients Increased Hand Hygiene Compliance Rates and Worlds First Monitored Point-of-Care Dispenser at APIC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):